World Patient Safety Day
By: Alere Staff
Publication Date: Sat, 03/01/2014
World Patient Safety Day occurs every July 25th. This year Alere is contributing to improving the safety of patients who take warfarin world-wide. Alere™ Anticoagulation Services provides safe and effective patient self-testing for patients taking warfarin. Warfarin remains one of the most effective treatments for blood clot prevention and ischemic stroke protection. At the same time however, warfarin is the second leading cause of major hospitalization behind the new drug dabigatran.1
The National Patient Safety Foundation is an organization dedicated to individuals and organizations committed to improving patient safety. Their goals include:
Alere is aligned with these goals working closely with physicians and their patients to increase testing frequency to reduce warfarin side effects. Studies3 and real world use of patient4 self-testing have shown weekly testing improves the quality of warfarin management and therefore patient safety.
Patients and their physician need to work together to improve the use of warfarin. Self-testing goes beyond where the patient tests, it allows patients to test up to weekly and be reimbursed to keep your INR in or close to your target range.5
For warfarin patients
Successful patient self-testing starts with the patient. Patients need to share their desire to test at home with their doctor. While the doctor will still manage all test results, testing more frequently will allow the patient a better understanding of where their INR is week to week.
For Healthcare Professionals
Offering patient self-testing to patients who can benefit from better warfarin control will reduce risks for patients and reduce the incidence of critical value INR test results.
Alere likes to think every day is patient safety day. Our services include: high quality personalized patient trainings with accredited trainers, an adherence service to avoid missed tests and a comprehensive patient education offering. Our results include a 74% TTR for over 4,500 weekly self-testers evaluated for two and a half years.4
Improving patient safety doesn’t mean you have to change drugs – it simply means improving the control of the drug you are already using.
- Institute for Safe Medication Practices. Annual Report. Monitoring FDA MedWatch Reports. Anticoagulants the leading reported drug risk in 2011. May 2012.
- National Patient Safety Foundation. Mission and Vision. 2013. Date assessed April 29th, 2013. http://www.npsf.org/about-us/mission-and-vision/
- Bloomfield H. et al. Meta-Analysis: Effect of PST and PSM of LT AC on Major Clinical Outcomes, Annals of Internal Medicine, April 2011, Vol. 154, No. 7.
- Ansell, J. March 2012. Patient Self-Testing: Real-World Experience Within a Comprehensive Support Service Represents a New Standard of Care, Attaining High Quality Anticoagulation Control. Poster presented at: American College of Cardiology.
- Center for Medicare and Medicaid Services. Decision Memo for Prothrombin Time (INR) Monitor for Home Anticoagulation Management (CAG-00087R) [Memorandum]. 2008. Baltimore, MD.